2017
DOI: 10.1186/s12879-016-2176-9
|View full text |Cite
|
Sign up to set email alerts
|

Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital

Abstract: BackgroundThe emergence and spread of Carbapenem-resistant Escherichia coli (CREC) is becoming a serious problem in Chinese hospitals, however, the data on this is scarce. Therefore, we investigate the risk factors for healthcare-associated CREC infection and study the incidence, antibiotic resistance and medical costs of CREC infections in our hospital.MethodsWe conducted a retrospective, matched case–control–control, parallel study in a tertiary teaching hospital. Patients admitted between January 2012 and D… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
30
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(34 citation statements)
references
References 35 publications
4
30
0
Order By: Relevance
“…Having surgery was a risk factor for acquiring CRE. This finding is in agreement with a previous study that described surgery as being more common in patients with CRE infection, and corroborates the finding that medical procedures play a significant role in increased susceptibility of hospitalized patients to certain infections 24 .…”
Section: Discussionsupporting
confidence: 93%
“…Having surgery was a risk factor for acquiring CRE. This finding is in agreement with a previous study that described surgery as being more common in patients with CRE infection, and corroborates the finding that medical procedures play a significant role in increased susceptibility of hospitalized patients to certain infections 24 .…”
Section: Discussionsupporting
confidence: 93%
“…Several risk factors for the occurrence of carbapenem-resistant (CR) bacteremia have been reported in different studies [13,14]. Wang Q et al pointed out that previous use of third-or fourthgeneration cephalosporins and carbapenems was an independent risk factor for carbapenem resistant Enterobacteriaceae infection in 94 episodes of nosocomial infections [15].…”
Section: Discussionmentioning
confidence: 99%
“…Finding the appropriate therapy became crucial and carbapenems emerged as 'best therapy' for ESBLproducing bacteria [25]. But in the time of antibiotics and resistance becoming popular, E. Coli also starts resistance to carbapenem that leading a high financial burden and increased mortality [27].…”
Section: Discussionmentioning
confidence: 99%